Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 9, Issue 3, 2006, Pages 225-233

  Coon, Keith D ^a   Siegel, Andrew M ^a   Yee, Stephanie J ^a   Dunckley, Travis L ^a   Mueller, Claudius ^b,c   Nagra, Rashed M ^d   Tourtellotte, Wallace W ^d   Reiman, Eric M ^a,e,f   Papassotiropoulos, Andreas ^a,g   Petersen, Floyd F ^b   Stephan, Dietrich A ^a,f   Kirsch, Wolff M ^b  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d Human Brain and Spinal Fluid Resource Center   (United States)

^e BANNER ALZHEIMER S INSTITUTE   (United States)

^f ARIZONA ALZHEIMER S CONSORTIUM   (United States)

^g UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; Iron; Iron metabolism; Iron regulatory protein 2; Neurodegeneration; Neurodegenerative disease

Indexed keywords

IRON; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ALLELISM; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BINDING SITE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOPLASM; DEGENERATIVE DISEASE; DNA SEQUENCE; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IREB2 GENE; IRON METABOLISM; IRON RESPONSIVE ELEMENT; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PILOT STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN RNA BINDING;

EID: 33747390485     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9301     Document Type: Article

References (31)

1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, Neurobiol Aging 18 (1997), S1-S2.
2. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller and D.J. Lipman, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res 25 (1997), 3389-3402.
3. R. Anand and J. Lindstrom, Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans, Genomics 13 (1992), 962-967.
4. D. Blacker, L. Bertram, A.J. Saunders, T.J. Moscarillo, M.S. Albert, H. Wiener, R.T. Perry, J.S. Collins, L.E. Harrell, R.C. Go, A. Mahoney, T. Beaty, M.D. Fallin, D. Avramopoulos, G.A. Chase, M.F. Folstein, M.G. McInnis, S.S. Bassett, K.J. Doheny, E.W. Pugh and R.E. Tanzi, Results of a high-resolution genome screen of 437 Alzheimer's disease families, Hum Mol Genet 12 (2003), 23-32.
5. S. Bodovitz, M.T. Falduto, D.E. Frail and W.L. Klein, Iron levels modulate alpha-secretase cleavage of amyloid precursor protein, J Neurochem 64 (1995), 307-315.
6. M.C. Chartier-Harlin, F. Crawford, H. Houlden, A. Warren, D. Hughes, L. Fidani, A. Goate, M. Rossor, P. Roques, J. Hardy et al., Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene, Nature 353 (1991), 844-846.
7. R.A. Cherny, J.T. Legg, C.A. McLean, D.P. Fairlie, X. Huang, C.S. Atwood, K. Beyreuther, R.E. Tanzi, C.L. Masters and A.I. Bush, Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion, J Biol Chem 274 (1999), 23223-23228.
8. O. Combarros, A. Alvarez-Arcaya, M. Sanchez-Guerra, J. Infante and J. Berciano, Candidate gene association studies in sporadic Alzheimer's disease, Dement Geriatr Cogn Disord 14 (2002), 41-54.
9. J.R. Connor, B.S. Snyder, J.L. Beard, R.E. Fine and E.J. Mufson, Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease, J Neurosci Res 31 (1992), 327-335.
10. L.J. Cook, L.W. Ho, A.E. Taylor, C. Brayne, J.G. Evans, J. Xuereb, N.J. Cairns, A. Pritchard, H. Lemmon, D. Mann, D. St Clair, D. Turic, P. Hollingworth, P.J. Moore, L. Jehu, N. Archer, S. Walter, C. Foy, A. Edmondson, J. Powell, S. Lovestone, M.J. Owen, J. Williams, C. Lendon and D.C. Rubinsztein, Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease, Neurosci Lett 358 (2004), 142-146.
11. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines and M.A. Pericak-Vance, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 261 (1993), 921-923.
12. D.A. Evans, H.H. Funkenstein, M.S. Albert, P.A. Scherr, N.R. Cook, M.J. Chown, L.E. Hebert, C.H. Hennekens and J.O. Taylor, Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported, Jama 262 (1989), 2551-2556.
13. M.W. Hentze, T.A. Rouault, J.B. Harford and R.D. Klausner, Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction, Science 244 (1989), 357-359.
14. D.E. Hoke, J.L. Tan, N.T. Ilaya, J.G. Culvenor, S.J. Smith, A.R. White, C.L. Masters and G.M. Evin, In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc, Febs J 272 (2005), 5544-5557.
15. D.K. Lahiri, Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene, J Mol Neurosci 23 (2004), 225-233.
16. T. LaVaute, S. Smith, S. Cooperman, K. Iwai, W. Land, E. Meyron-Holtz, S.K. Drake, G. Miller, M. Abu-Asab, M. Tsokos, R. Switzer 3rd, A. Grinberg, P. Love, N. Tresser and T.A. Rouault, Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice, Nat Genet 27 (2001), 209-214.
17. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, W.H. Pettingell, C.E. Yu, P.D. Jondro, S.D. Schmidt, K. Wang et al., Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science 269 (1995), 973-977.
18. R.D. Moir, C.S. Atwood, D.M. Romano, M.H. Laurans, X. Huang, A.I. Bush, J.D. Smith and R.E. Tanzi, Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations, Biochemistry 38 (1999), 4595-4603.
19. S. Murayama and Y. Saito, Neuropathological diagnostic criteria for Alzheimer's disease, Neuropathology 24 (2004), 254-260.
20. W.Y. Ong and B. Halliwell, Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann N Y Acad Sci 1012 (2004), 51-64.
21. D.S. Prestridge, Predicting Pol II promoter sequences using transcription factor binding sites, J Mol Biol 249 (1995), 923-932.
22. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R.E. Tanzi and C.L. Masters, Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial, Arch Neurol 60 (2003), 1685-1691.
23. K.J. Robson, D.J. Lehmann, V.L. Wimhurst, K.J. Livesey, M. Combrinck, A.T. Merryweather-Clarke, D.R. Warden and A.D. Smith, Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease, J Med Genet 41 (2004), 261-265.
24. J.T. Rogers, J.D. Randall, C.M. Cahill, P.S. Eder, X. Huang, H. Gunshin, L. Leiter, J. McPhee, S.S. Sarang, T. Utsuki, N.H. Greig, D.K. Lahiri, R.E. Tanzi, A.I. Bush, T. Giordano and S.R. Gullans, An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript, J Biol Chem 277 (2002), 45518-45528.
25. T.A. Rouault, C.K. Tang, S. Kaptain, W.H. Burgess, D.J. Haile, F. Samaniego, O.W. McBride, J.B. Harford and R.D. Klausner, Cloning of the cDNA encoding an RNA regulatory protein - the human iron-responsive element-binding protein, Proc Natl Acad Sci USA 87 (1990), 7958-7962.
26. W.K. Scott, E.R. Hauser, D.E. Schmechel, K.A. Welsh-Bohmer, G.W. Small, A.D. Roses, A.M. Saunders, J.R. Gilbert, J.M. Vance, J.L. Haines and M.A. Pericak-Vance, Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22, Am J Hum Genet 73 (2003), 1041-1051.
27. D.J. Selkoe, Alzheimer's disease is a synaptic failure, Science 298 (2002), 789-791.
28. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman et al., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature 375 (1995), 754-760.
29. M.A. Smith, K. Wehr, P.L. Harris, S.L. Siedlak, J.R. Connor and G. Perry, Abnormal localization of iron regulatory protein in Alzheimer's disease, Brain Res 788 (1998), 232-236.
30. T. Teaktong, A.J. Graham, J.A. Court, R.H. Perry, E. Jaros, M. Johnson, R. Hall and E.K. Perry, Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology, J Neurol Sci 225 (2004), 39-49.
31. K.J. Wu, A. Polack and R. Dalla-Favera, Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC, Science 283 (1999), 676-679.